Senores Pharmaceuticals Acquires 51% Stake in Delaware-Based Zoraya Pharmaceuticals LLC

Senores Pharmaceuticals (SPI) has acquired a 51% stake in Zoraya Pharmaceuticals LLC, based in Delaware, USA. The acquisition was made through the subscription of membership interest, effectively making Zoraya a step-down subsidiary of SPI. This development marks an expansion of SPI’s operations and presence within the United States pharmaceutical market.

The move is expected to strengthen SPI’s footprint in the U.S., aligning with its strategic goals for growth and international collaboration. By acquiring majority ownership in Zoraya Pharmaceuticals, SPI gains access to new opportunities within the American healthcare sector while expanding its operational capabilities abroad.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 6, 2025

Author

GOAI